2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益

2017-03-20 美国胃肠病协会 Gastroenterology. 2017 Mar;152(4):706-715.

本文的主要目的是评估长期应用质子泵抑制剂的相关风险,主要聚焦于长期应用质子泵抑制剂的3种疾病适应症:胃食管反流病(GERD)、巴雷特食管(BE)和非甾体类抗炎药(NSAID)出血的预防。

中文标题:

2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益

英文标题:

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

发布机构:

美国胃肠病协会

发布日期:

2017-03-20

简要介绍:

本文的主要目的是评估长期应用质子泵抑制剂的相关风险,主要聚焦于长期应用质子泵抑制剂的3种疾病适应症:胃食管反流病(GERD)、巴雷特食管(BE)和非甾体类抗炎药(NSAID)出血的预防。


拓展指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益)] GetToolGuiderByIdResponse(projectId=1, id=3ef4f1c001a513e9, title=2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益, enTitle=The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association., guiderFrom=Gastroenterology. 2017 Mar;152(4):706-715., authorId=null, author=, summary=本文的主要目的是评估长期应用质子泵抑制剂的相关风险,主要聚焦于长期应用质子泵抑制剂的3种疾病适应症:胃食管反流病(GERD)、巴雷特食管(BE)和非甾体类抗炎药(NSAID)出血的预防。, cover=, journalId=null, articlesId=null, associationId=102, associationName=美国胃肠病协会, associationIntro=美国胃肠病协会成立于1897年,已包括来自全球各地17000个成员参与消化所有方面的研究、实践和前沿。提供各项关于胃肠道疾病的指南和研究,发布两本期刊,都为月刊,每年5月份会举行年会。, copyright=0, guiderPublishedTime=Mon Mar 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=本文的主要目的是评估长期应用质子泵抑制剂的相关风险,主要聚焦于长期应用质子泵抑制剂的3种疾病适应症:胃食管反流病(GERD)、巴雷特食管(BE)和非甾体类抗炎药(NSAID)出血的预防。 <div><br> </div> 拓展指南:, tagList=[TagDto(tagId=3126, tagName=应用), TagDto(tagId=10213, tagName=质子泵), TagDto(tagId=5188, tagName=抑制剂), TagDto(tagId=643, tagName=风险), TagDto(tagId=15834, tagName=获益)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=34, categoryName=全科医学, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3375, appHits=247, showAppHits=0, pcHits=2240, showPcHits=1405, likes=127, shares=2, comments=5, approvalStatus=1, publishedTime=Fri Jun 09 09:24:59 CST 2017, publishedTimeString=2017-03-20, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri Jun 09 09:24:59 CST 2017, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 20:16:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益)])
2017 AGA实践建议:长期应用质子泵抑制剂的风险和获益
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998885, encodeId=2835998885bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd555440880, createdName=ms9000000543233406, createdTime=Mon Jul 12 20:37:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902818, encodeId=7ca9902818e7, content=学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:03:22 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238686, encodeId=206623868696, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ede2012638, createdName=1e1f3761m34(暂无匿称), createdTime=Wed Aug 30 13:35:52 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217090, encodeId=179321e09027, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:25 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2021-07-12 ms9000000543233406

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998885, encodeId=2835998885bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd555440880, createdName=ms9000000543233406, createdTime=Mon Jul 12 20:37:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902818, encodeId=7ca9902818e7, content=学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:03:22 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238686, encodeId=206623868696, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ede2012638, createdName=1e1f3761m34(暂无匿称), createdTime=Wed Aug 30 13:35:52 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217090, encodeId=179321e09027, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:25 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2020-11-27 公冶花

    学习进步

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=998885, encodeId=2835998885bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd555440880, createdName=ms9000000543233406, createdTime=Mon Jul 12 20:37:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902818, encodeId=7ca9902818e7, content=学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:03:22 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238686, encodeId=206623868696, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ede2012638, createdName=1e1f3761m34(暂无匿称), createdTime=Wed Aug 30 13:35:52 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217090, encodeId=179321e09027, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:25 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-08-30 1e1f3761m34(暂无匿称)

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=998885, encodeId=2835998885bd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd555440880, createdName=ms9000000543233406, createdTime=Mon Jul 12 20:37:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902818, encodeId=7ca9902818e7, content=学习进步, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:03:22 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238686, encodeId=206623868696, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ede2012638, createdName=1e1f3761m34(暂无匿称), createdTime=Wed Aug 30 13:35:52 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217090, encodeId=179321e09027, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:25 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-06-30 明天会更好!

    感谢分享!继续关注!

    0